Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors

  1. Nieto, Y.
  2. Aldaz, A.
  3. Rifón, J.
  4. Pérez-Calvo, J.
  5. Zafra, A.
  6. Zufia, L.
  7. Viúdez, A.
  8. Viteri, S.
  9. Aramendía, J.M.
  10. Aristu, J.
  11. Centeno, C.
  12. Moreno, M.
  13. Sayar, O.
  14. Hernández, M.
Revue:
Biology of Blood and Marrow Transplantation

ISSN: 1083-8791,  1523-6536

Année de publication: 2007

Volumen: 13

Número: 11

Pages: 1324-1337

Type: Article

DOI: 10.1016/J.BBMT.2007.07.008 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus